The right antibiotic,
the right dose,
every time.
Demed guides any doctor — not just infectious disease specialists — through medication selection, dosing, and de-escalation for infection cases. Every recommendation is grounded to the guidelines your hospital already follows, cited line by line. Not a chatbot. A clinical instrument.
AMR isn't the disease. It's the symptom of a harder problem doctors face on every ward round.
Any physician — cardiologist, surgeon, internist, not just an infectious disease specialist — can end up choosing an empiric antibiotic under time pressure, with an incomplete picture of local resistance patterns, renal function, allergy cross-reactivity, and which of a dozen overlapping guideline documents actually applies to this patient, right now.
Get that choice wrong and two things happen: the patient's treatment is delayed or suboptimal, and every inappropriate or overly broad antibiotic prescribed adds to the resistance burden the next patient will face. AMR is the population-level scar left by thousands of individually rushed decisions.
Demed doesn't generate answers. It retrieves and cites them.
Ask a general-purpose LLM a clinical question and it will answer — fluently, confidently, and sometimes wrong, with no way to check its work. Demed is architecturally different: a deterministic rules engine handles anything calculable (renal dosing, allergy cross-reactivity) and never guesses, while every guideline-based recommendation is retrieved from a curated corpus of IDSA, ICMR, and WHO source documents and shown with its citation, not asserted from memory.
Deterministic where it must be
Dose calculations and allergy blocks run in code, not a language model — never a guess where a wrong answer has real consequences.
Every claim is cited
Recommendations show which guideline, which year, which section — not "trust me."
India-specific, not translated
Grounded in ICMR's own national resistance surveillance data — not just Western guideline assumptions.
From admission to de-escalation, in the same workflow you already run.
Empiric therapy
One recommendation, one primary drug, full confidence breakdown — never a list to sift through under pressure.
Culture-directed de-escalation
Once cultures return, Demed re-ranks toward the narrowest effective agent — Access before Watch before Reserve.
According to the IDSA 2025 complicated UTI guideline, empiric therapy depends on a four-step process: (1) assess illness severity, (2) evaluate risk factors for resistant organisms, (3) assess patient-specific factors, (4) consider the local antibiogram. Nitrofurantoin and oral fosfomycin are explicitly excluded — they don't achieve adequate levels in renal parenchyma or blood.
Ask Demed
Any clinical question, answered from the guideline corpus with citations — not a free-floating LLM opinion.
Voice input and multi-page document upload (lab reports, discharge summaries) are in active development for the next pilot phase — we're working on it and will update pilot participants directly as each capability goes live.
Bring Demed to your hospital.
We're running a focused pilot with hospitals ready to validate a guideline-grounded co-pilot on real cases.
Request a pilot